Rafi Allos

AstraZeneca Refused Interim Injunction On SPC For Blockbuster Diabetes Treatment Against Glenmark But Swiftly Obtains Permission To Appeal

A New Approach To Regulation By The MHRA And NICE

UPC Revocation Actions: What Is A Reasonable Number Of Auxiliary Requests?